Public Health | June 28, 2022
50%+ patients delay cataract surgeries in India: Survey
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications
Subscribe To Our Newsletter & Stay Updated
